Dr. Balagula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Box# 8
New York, NY 10065Phone+1 212-639-5809
Education & Training
- Johns Hopkins UniversityResidency, Dermatology, 2011 - 2015
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Radiology-Diagnostic, 2008 - 2009
- Rutgers Health/Robert Wood Johnson Medical SchoolInternship, Internal Medicine, 2007 - 2008
- Rutgers Robert Wood Johnson Medical SchoolClass of 2007
Certifications & Licensure
- NY State Medical License 2009 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 6 citationsSynergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipientsYevgeniy Balagula, Sewon Kang, Manisha J. Patel
Photodermatology, Photoimmunology & Photomedicine. 2015-01-01 - 41 citationsThe risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis.Yevgeniy Balagula, Shenhong Wu, Xiao Su, Darren R. Feldman, Mario E. Lacouture
Investigational New Drugs. 2012-08-01 - 61 citationsThe significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesionsYevgeniy Balagula, Ralph P. Braun, Harold S. Rabinovitz, Stephen W. Dusza, Alon Scope
Journal of the American Academy of Dermatology. 2012-08-01
Lectures
- Complex Medical Dermatology: Clinicopathologic CorrelationAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
Other
- Acneiform eruption secondary to epidermal growth factor (EGFR) inhibitorsBalagula Y, Lacouture ME
http://www.uptodate.com/contents/acneiform-eruption-secondary-to-epidermal-growth-factor-egfr-inhibi
UpToDate, Wolters Kluwer Health - 2013-02-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: